GM3 and diabetes

Glycoconjugate Journal

Volumn 31, Issue 3, 2014, Pages 193-197

  Inokuchi, Jin Ichi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Diabetes; Diversity of ceramide structure; Ganglioside GM3; Insulin resistance; Lipid rafts; Membrane microdomains

Indexed keywords

CERAMIDE; GANGLIOSIDE GM3; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADIPOCYTE; ADIPOSE TISSUE; BINDING AFFINITY; CARBOHYDRATE SYNTHESIS; DISEASE MARKER; DISEASE SEVERITY; GENE EXPRESSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID RAFT; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; UPREGULATION; AMINO ACID SEQUENCE; BLOOD; DIABETES MELLITUS; HUMAN; METABOLISM; MOLECULAR GENETICS; PATHOPHYSIOLOGY;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; DIABETES MELLITUS; G(M3) GANGLIOSIDE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MOLECULAR SEQUENCE DATA;

EID: 84897535795     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-013-9516-4     Document Type: Review

References (26)

1. Regina-Todeschini, A., Hakomori, S.I.: Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta 1780, 421-33 (2008)
2. Sabourdy, F., Kedjouar, B., Sorli, S.C., Colié, S., Milhas, D., Salma, Y., Levade, T.: Functions of sphingolipid metabolism in mammals- lessons fromgenetic defects. Biochim. Biophys. Acta 1781, 145-183 (2008)
3. Ishii, A., Ohta, M., Watanabe, Y., Matsuda, K., Ishiyama, K., Sakoe, K., Nakamura, M., Inokuchi, J., Sanai, Y., Saito, M.: Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase. J. Biol. Chem. 273, 31652-31655 (1998)
4. Inokuchi, J.: Physiopathological function of hematoside (GM3 ganglioside). Proc. Jpn. Acad., Ser. B 87, 179-198 (2011)
5. Zoncu, R., Efeyan, A., Sabatini, D.M.: mTOR:from growth signal integration to cancer, diabetes and aging. Nat. Rev. Mol. Cell Biol. 12, 21-35 (2011)
6. Guo, D., Donner, D.B.: Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3 T3-L1 adipocytes. J. Biol. Chem. 271, 615-618 (1996)
7. Kabayama, K., Sato, T., Kitamura, F., Uemura, S., Kang, B.W., Igarashi, Y., Inokuchi, J.: TNF alpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 15, 21-29 (2005)
8. Tagami, S., Inokuchi, J., Kabayama, S., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., Sakaue, S., Igarashi, Y.: Ganglioside GM3 participates in the pathological conditions of insulin resistance. J. Biol. Chem. 277, 3085-3092 (2002)
9. Inokuchi, J., Radin, N.: Preparation of the active isomer of 1-phenyl2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase. J. Lipid Res. 28, 565-571 (1987)
10. Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J.L., Werth, N., Sandhoff, R., Sandhoff, K., Proia, R.L.: Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc. Natl. Acad. Sci.U. S.A. 100, 3445-3449 (2003)
11. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M.: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993)
12. Zhao, H., Przybylska, M., Wu, I.H., Zhang, J., Siegel, C., Komarnitsky, S., Yew, N.S., Cheng, S.H.: Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes 56, 1210-1218 (2007)
13. Aerts, J.M., Ottenhoff, R., Powlson, A.S., Grefhorst, A., van Eijk, M., Dubbelhuis, P.F., Aten, J., Kuipers, F., Serlie, M.J., Wennekes, T., Sethi, J.K., O'Rahilly, S., Overkleeft, H.S.: Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes 56, 1341-1349 (2007)
14. Kabayama, K., Sato, T., Saito, K., Loberto, N., Prinetti, A., Sonnino, S., Kinjo, M., Igarashi, Y., Inokuchi, J.: Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 104, 13678-13683 (2007)
15. Ohashi, M.: A comparison of the ganglioside distributions of fat tissues in various animals by two-dimensional thin layer chromatography. Lipids 14, 52-57 (1979)
16. Hakomori, S.I.: Inaugural article: the glycosynapse. Proc. Natl. Acad. Sci. U. S. A. 99, 225-232 (2002)
17. Sonnino, S., Mauri, L., Chigorno, V., Prinetti, A.: Gangliosides as components of lipid membrane domains. Glycobiology 17, 1R-13R (2007)
18. Chavez, J.A., Siddique, M.M., Wang, S.T., Ching, J., Shayman, J.A., Summers, S.A.: Ceramides and Glucosylceramides are Independent Antagonists of Insulin Signaling. J. Biol. Chem. (2013). 10.1074/jbc.M113.522847
19. Park, J.-W., Park, W.-J., Kuperman, Y., Boura-Halfon, S., Pewzner-Jung, Y., Futerman, A.H.: Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. Hepatology 257, 525-532 (2013)
20. Senn, H.J., Orth, M., Fitzke, E., Wieland, H., Gerok, W.: Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur. J. Biochem. 181, 657-662 (1989)
21. Sato, T., Nihei, Y., Nagafuku, M., Tagami, S., Chin, R., Kawamura, M., Miyazaki, S., Suzuki, M., Sugahara, S., Takahashi, Y., Saito, A., Igarashi, Y., Inokuchi, J.: Circulating levels of ganglioside GM3 in metabolic syndrome: a pilot study. Obes. Res. Clin. Pract. 2, 231-238 (2008)
22. Austin, M.A., Breslow, J.L., Hennekens, C.H., Buring, J.E., Willett, W.C., Krauss, R.M.: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260, 1917-1921 (1988)
23. de Graaf, J., Hak-Lemmers, H.L., Hectors, M.P., Demacker, P.N., Hendriks, J.C., Stalenhoef, A.F.: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler. Thromb. 11, 298-306 (1991)
24. Tribble, D.L., Krauss, R.M., Lansberg, M.G., Thiel, P.M., van den Berg, J.J.: Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions. J. Lipid Res. 36, 662-671 (1995)
25. Bobryshev, Y.V., Lord, R.S., Golovanova, N.K., Gracheva, E.V., Zvezdina, N.D., Sadovskaya, V.L., Prokazova, N.V.: Incorporation and localisation of ganglioside GM3 in human intimal atherosclerotic lesions. Biochim. Biophys. Acta 1361, 287-294 (1997)
26. Bobryshev, Y.V., Lord, R.S., Golo vanova, N.K., Gracheva, E.V., Zvezdina, N.D., Prokazova, N.V.: Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta. Hypothetical role of ganglioside GM3 in foam cell formation. Biochim. Biophys. Acta 1535, 87-99 (2001)